Clinical Trial Update: Drug Use Investigation for IMIGRAN Tablet

View source ↗

Summary

A completed clinical trial evaluating the use of Imigran (sumatriptan) tablets for migraine disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Imigran (sumatriptan)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Migraine Disorders | Status: COMPLETED